ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,242,000 | -65.8% | 13,030 | -75.1% | 0.02% | -62.5% |
| Q2 2021 | $6,562,000 | -67.5% | 52,294 | -64.9% | 0.05% | -68.6% |
| Q1 2021 | $20,194,000 | -28.1% | 148,912 | -32.2% | 0.15% | -26.4% |
| Q4 2020 | $28,093,000 | +77.0% | 219,581 | +55.7% | 0.21% | +49.6% |
| Q3 2020 | $15,868,000 | +330.1% | 141,012 | +264.1% | 0.14% | +321.2% |
| Q2 2020 | $3,689,000 | +5.9% | 38,724 | -0.1% | 0.03% | -15.4% |
| Q1 2020 | $3,485,000 | – | 38,775 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |